STOCKTON, CA, January 23, 2025 /24-7PressRelease/ -- Todd Quevillon Barker, PhD, has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Dr. Barker is an established professional who has dedicated his career to medical devices. In 2023, he launched Todd Barker Consulting LLC as the company's president. As part of his responsibilities, he consults with companies requiring quality management and system development improvements for existing systems while working collaboratively with engineers. As a recognized professional in quality management systems, quality compliance for the Federal Drug Administration, and international standard compliance for medical devices, Dr. Barker is sought-after for his expertise.

To expand his company, Dr. Barker aims to hire additional employees, including several family members with technical backgrounds, to focus on regulatory compliance and medical products. Moreover, he aspires to support the safe implementation of artificial intelligence and machine learning.

As an accomplished scientist, Dr. Barker has contributed significantly to medical research. He most notably developed a groundbreaking PCR platform for nucleic acid detection, which detects HIV, hepatitis viruses, and West Nile virus in donated blood. As a result, HIV was reduced in major hotspots worldwide, saving countless lives. In addition to his research, Dr. Barker co-authored numerous scientific papers on chemometrics with Stephen Brown from the University of Delaware.

Dr. Barker began his career in the industry in 1991 with Baxter International, where he was involved in immunodiagnostics. He was subsequently recruited by Biocontrol Technology and Abbot Diagnostics before being hired by Roche. Over the next 20 years, he worked as a senior manager of Ventana medical systems and Roche tissue diagnostics, as a manager of design quality engineering, and as a senior manager of Roche sequencing solutions. During his tenure at Roche, Dr. Barker also worked at the Swiss Instrument Center in Switzerland for the APAC region, where he worked internationally with blood bankers. Following his tenure, Dr. was a health quality lead at Apple from 2020 to 2023.

Active in his community, Dr. Barker has been affiliated with the Boy Scouts of America. He has also been a member of Toastmasters International.

Highly educated, Dr. Barker earned a bachelor's degree in analytical chemistry and a master's degree in environmental electro-analytical chemistry from the University of South Dakota in 1981 and 1984, respectively. Continuing his education, he received a Doctor of Philosophy in analytical chemistry and chemometrics from the University of Delaware in 1989 and postdoctoral coursework at the University of Hawaii in 1991. Dr. Barker is recognized as a certified software quality engineer through ASQ-World Headquarters and a certified Six Sigma green belt.

# # #